• 1. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 2. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 3. An antioxidative galactomannan extracted from Chinese Sesbania cannabina enhances immune activation of macrophage cells?
  Chongyang Zhu,Xiaojia Bian,Xin Jia,Ning Tang,Yongqiang Cheng Food Funct., 2020,11, 10635-10644
• 4. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 5. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Piperidines Benzylpiperidines 4-benzylpiperidines

Introduction to 4-(3-Methoxybenzyl)piperidine and Its Significance in Modern Chemical Research

4-(3-Methoxybenzyl)piperidine, with the CAS number 150019-61-7, is a compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology. This piperidine derivative, characterized by its unique structural motif, exhibits a range of potential applications that span from drug discovery to the development of novel bioactive molecules. The compound's chemical structure, featuring a piperidine ring linked to a 3-methoxybenzyl group, imparts distinct physicochemical properties that make it a valuable scaffold for synthetic chemists and biologists alike.

The 3-methoxybenzyl moiety, in particular, contributes to the compound's overall solubility and stability, which are critical factors in pharmaceutical formulations. This feature allows for easier handling and integration into various biochemical assays, making 4-(3-Methoxybenzyl)piperidine a versatile building block for medicinal chemists. Recent studies have highlighted its role in the synthesis of potent inhibitors targeting various biological pathways, including those involved in neurodegenerative diseases and cancer.

In the realm of drug discovery, the CAS no 150019-61-7 identifier is often associated with compounds that exhibit promising pharmacological profiles. The piperidine core is a well-documented pharmacophore in medicinal chemistry, known for its ability to interact with biological targets such as enzymes and receptors. The introduction of the 3-methoxybenzyl group further modulates these interactions, leading to enhanced binding affinity and selectivity. This has been particularly observed in the development of kinase inhibitors, where 4-(3-Methoxybenzyl)piperidine derivatives have shown remarkable efficacy.

Recent advancements in computational chemistry have enabled researchers to predict the binding modes of 4-(3-Methoxybenzyl)piperidine with high precision. Molecular docking studies have revealed that this compound can effectively disrupt key protein-protein interactions implicated in inflammatory responses. The methoxy group on the benzyl moiety plays a crucial role in these interactions by serving as a hydrogen bond acceptor, thereby stabilizing the enzyme-inhibitor complex. Such insights have guided the optimization of analogs with improved pharmacokinetic profiles.

The synthesis of 4-(3-Methoxybenzyl)piperidine has been refined through multiple methodologies, each offering distinct advantages in terms of yield and purity. Traditional approaches involving nucleophilic substitution reactions have been complemented by more modern techniques such as transition-metal-catalyzed cross-coupling reactions. These advancements have not only improved the accessibility of the compound but also opened new avenues for structural diversification. For instance, functionalization at different positions on the piperidine ring has led to a series of derivatives with tailored biological activities.

One of the most compelling aspects of 4-(3-Methoxybenzyl)piperidine is its potential in addressing unmet medical needs. Ongoing clinical trials are evaluating its efficacy as an adjunct therapy for patients suffering from chronic pain conditions. The compound's ability to modulate neurotransmitter release has sparked interest among neuroscientists who are exploring novel treatments for neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease. Preclinical data suggests that 4-(3-Methoxybenzyl)piperidine can enhance synaptic plasticity without causing significant side effects.

The role of CAS no 150019-61-7 in academic research cannot be overstated. It serves as a benchmark compound for teaching and training purposes, helping students understand complex concepts in organic synthesis and pharmacology. The availability of high-quality reference materials ensures that researchers can reliably reproduce experiments and share findings across international collaborations. This standardization is essential for advancing scientific knowledge and translating laboratory discoveries into clinical applications.

Future directions in the study of 4-(3-Methoxybenzyl)piperidine include exploring its potential as an antiviral agent. Preliminary studies have shown that derivatives of this compound can inhibit viral protease enzymes, which are critical for viral replication. By targeting these enzymes specifically, researchers aim to develop therapies that are both effective and less toxic compared to existing antiviral drugs. The methoxy group's electron-donating properties are believed to enhance binding interactions with viral proteins, providing a rational basis for further development.

The environmental impact of synthesizing and utilizing 4-(3-Methoxybenzyl)piperidine is another area of growing interest. Green chemistry principles are being applied to develop more sustainable synthetic routes that minimize waste and reduce energy consumption. For example, catalytic methods that employ recyclable ligands have been investigated as alternatives to traditional stoichiometric approaches. Such innovations align with global efforts to promote sustainable practices in pharmaceutical manufacturing.

In conclusion, 4-(3-Methoxybenzyl)piperidine (CAS no 150019-61-7) represents a significant advancement in chemical research with far-reaching implications for drug development. Its unique structural features make it an invaluable tool for medicinal chemists seeking to design novel therapeutics targeting diverse diseases. As research continues to uncover new applications for this compound, it is likely to remain at the forefront of pharmaceutical innovation for years to come.

• 325808-20-6(4-(3-methoxyphenyl)piperidine hydrochloride)
• 37581-27-4(4-(4-methoxyphenyl)methylpiperidine hydrochloride)
• 179480-58-1(3-(3-Methoxybenzyl)piperidine Hydrochloric Acid Salt)
• 654662-60-9(4-[2-(4-methoxyphenyl)ethyl]piperidine)
• 37581-26-3(4-(4-methoxyphenyl)methylpiperidine)
• 75999-98-3(Piperidine,4-[3-(4-methoxyphenyl)propyl]-, hydrochloride (1:1))
• 136422-65-6(3-(4-Methoxybenzyl)piperidine)
• 149986-58-3(4-(3-Methoxybenzyl)piperidine hydrochloride)
• 56753-78-7(Piperidine, 4-[3-(4-methoxyphenyl)propyl]-)
• 67259-62-5(4-(4-Methoxyphenyl)piperidine)